Complement Is Activated by IgG Hexamers Assembled at the Cell Surface

Christoph A. Diebolder(Utrecht University), Frank J. Beurskens(Genmab (Netherlands)), Rob N. de Jong(Genmab (Netherlands)), Roman I. Koning(Leiden University Medical Center), Kristin Strumane(Genmab (Netherlands)), Margaret A. Lindorfer(University of Virginia), Marleen Voorhorst(Genmab (Netherlands)), Deniz Ugurlar(Utrecht University), Sara Rosati(Utrecht University), Albert J. R. Heck(Utrecht University), Jan G. J. van de Winkel(University Medical Center Utrecht), Ian A. Wilson(Scripps Research Institute), Abraham J. Koster(Leiden University Medical Center), Ronald P. Taylor(University of Virginia), Erica Ollmann Saphire(Scripps Research Institute), Dennis R. Burton(Scripps Research Institute), Janine Schuurman(Genmab (Netherlands)), Piet Gros(Utrecht University), Paul W.H.I. Parren(Genmab (Netherlands))
Science
March 13, 2014
Cited by 778

Abstract

Complement activation by antibodies bound to pathogens, tumors, and self antigens is a critical feature of natural immune defense, a number of disease processes, and immunotherapies. How antibodies activate the complement cascade, however, is poorly understood. We found that specific noncovalent interactions between Fc segments of immunoglobulin G (IgG) antibodies resulted in the formation of ordered antibody hexamers after antigen binding on cells. These hexamers recruited and activated C1, the first component of complement, thereby triggering the complement cascade. The interactions between neighboring Fc segments could be manipulated to block, reconstitute, and enhance complement activation and killing of target cells, using all four human IgG subclasses. We offer a general model for understanding antibody-mediated complement activation and the design of antibody therapeutics with enhanced efficacy.


Related Papers

No related papers found

Powered by citation graph analysis